Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
30–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Overtly healthy males or females of non-childbearing potential and who have given consent and are reliable and willing to make themselves available for the duration of the study and are willing to follow study procedures
AD participants must be at least 50 years of age and have diagnostic criteria consistent with either mild cognitive impairment due to AD or mild-to moderate AD and have a positive florbetapir positron emission tomography (PET) scan
You may not be if
Have known allergies to LY3303560, related compounds or any components of the formulation, or history of significant atopy
Have an increased risk of seizures
For AD participants, evidence of macrohemorrhage or greater than 4 microhemorrhage by magnetic resonance imaging (MRI)
Clareo Health | A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)
